Hepatic ACAT3 in Cholesterol–Bile Acid–Microbiota Signaling
Current understanding
ACAT3 (acyl-CoA:cholesterol acyltransferase 3) is a liver-enriched cholesterol-esterifying enzyme proposed as an upstream node coupling hepatic cholesterol handling to bile-acid output, gut microbiota composition, and systemic energy homeostasis, based on a single male-mouse genetic characterization [animal-model]. Hepatic ACAT3 expression is reported to fall with obesity, diabetes, and aging, suggesting it as a candidate age-linked lesion in the liver arm of the gut–liver–metabolism axis, though evidence is currently confined to male mice with no human translation data [animal-model].
Evidence log
- 2026-06-08 — ACAT3 controls hepatic cholesterol metabolism and modulates systemic energy homeostasis of male mice.: cross-connection with gut-microbiota-bile-acid-fxr-fgf15-muscle: ACAT3-driven remodeling of the hepatic bile-acid pool is the upstream substrate for downstream ileal FXR–FGF15 signaling that the muscle axis depends on; ACAT3 loss with age is a candidate mechanism for age-related weakening of this signaling arm. (novelty: 3)